the swiss chemicals maker clariant missed third quarter profits.a fell 30% to 139 million swiss in the period. shares down 5%. well, delighted to say conrad keijzer joins us. co conrad, tough day on the performance. you are among restructuring. talk us through what you make of the current environment and how you're responding. >> yeah, steve, good morning. good to be with you. if you look at the third quarter, a slight miss in earnings, but if you actually corrected for some restructuring charges we took, we weresconsen. we were pleased with the overall. ebitda margins down from last year. lower top line growth of minus 1% in local currency. one comment about that that was entirely driven by delay in orders for catalyst down 20%, but the rest of the business in cla clariant is well. >> i have a friend of mine who is seeing delays of the signing of the deal or enactment of the orders as well. is that a similar picture? the pipeline looks like it's there, but a delay from the clients at the moment and pushing the deals from imm immediacy? >> yeah, if